143 related articles for article (PubMed ID: 17259178)
1. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype.
MacKenzie DA; Schartner J; Lin J; Timmel A; Jennens-Clough M; Fathman CG; Seroogy CM
J Biol Chem; 2007 Mar; 282(13):9696-9702. PubMed ID: 17259178
[TBL] [Abstract][Full Text] [Related]
2. Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures.
Schartner JM; Singh AM; Dahlberg PE; Nettenstrom L; Seroogy CM
Clin Exp Immunol; 2009 Feb; 155(2):348-56. PubMed ID: 19040605
[TBL] [Abstract][Full Text] [Related]
3. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.
Seroogy CM; Soares L; Ranheim EA; Su L; Holness C; Bloom D; Fathman CG
J Immunol; 2004 Jul; 173(1):79-85. PubMed ID: 15210761
[TBL] [Abstract][Full Text] [Related]
4. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
[TBL] [Abstract][Full Text] [Related]
5. Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.
Mukai A; Iijima H; Hiyama S; Fujii H; Shinzaki S; Inoue T; Shiraishi E; Kawai S; Araki M; Hayashi Y; Kondo J; Mizushima T; Kanto T; Egawa S; Nishida T; Tsujii M; Takehara T
J Gastroenterol; 2014 Dec; 49(12):1524-35. PubMed ID: 24356810
[TBL] [Abstract][Full Text] [Related]
6. Induction of CD4
Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
[TBL] [Abstract][Full Text] [Related]
7. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
Su LL; Iwai H; Lin JT; Fathman CG
J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.
Kriegel MA; Rathinam C; Flavell RA
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371
[TBL] [Abstract][Full Text] [Related]
10. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
[TBL] [Abstract][Full Text] [Related]
11. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
12. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
[TBL] [Abstract][Full Text] [Related]
14. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
15. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.
Ochando JC; Yopp AC; Yang Y; Garin A; Li Y; Boros P; Llodra J; Ding Y; Lira SA; Krieger NR; Bromberg JS
J Immunol; 2005 Jun; 174(11):6993-7005. PubMed ID: 15905542
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
18. Role of the E3 ubiquitin ligase gene related to anergy in lymphocytes in glucose and lipid metabolism in the liver.
Nakamichi S; Senga Y; Inoue H; Emi A; Matsuki Y; Watanabe E; Hiramatsu R; Ogawa W; Kasuga M
J Mol Endocrinol; 2009 Feb; 42(2):161-9. PubMed ID: 19060180
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
Nurieva RI; Zheng S; Jin W; Chung Y; Zhang Y; Martinez GJ; Reynolds JM; Wang SL; Lin X; Sun SC; Lozano G; Dong C
Immunity; 2010 May; 32(5):670-80. PubMed ID: 20493730
[TBL] [Abstract][Full Text] [Related]
20. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
Curotto de Lafaille MA; Lino AC; Kutchukhidze N; Lafaille JJ
J Immunol; 2004 Dec; 173(12):7259-68. PubMed ID: 15585848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
